Evaluate the Pharmacokinetic and Pharmacodynamic Profile, Safety, and Tolerability of Escalating Single Dose & Multiple Dose by Using Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitits B Patients
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Albinterferon alfa 2B (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Tianjin SinoBiotech
- 29 Mar 2021 Status changed from recruiting to completed.
- 12 Sep 2019 Planned End Date changed from 28 May 2019 to 28 Oct 2019.
- 09 Apr 2019 Planned End Date changed from 28 Feb 2019 to 28 May 2019.